1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1038)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (286)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (215)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1038)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (286)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (215)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Convalescence after radical orchiectomy: Detailing surgical recovery with a novel electronic patient reported outcome (ePRO) platform
    Journal Article

    Gold, S. A.; Jayalath, V. H.; Yu, R.; Baky, F.; Liso, N.; Williams, B.; Tin, A. L.; Carlsson, S.; Cracchiolo, J.; Vickers, A. J.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results: CHRONIC MYELOID LEUKEMIA
    Journal Article

    Cortes, J. E.; Lang, F.; Rea, D.; Hochhaus, A.; Breccia, M.; Goh, Y. T.; Heinrich, M. C.; Hughes, T. P.; Janssen, J. J. W. M.; le Coutre, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Allogeneic chimeric antigen receptor T-cell products cemacabtagene ansegedleucel/ALLO-501 in relapsed/refractory large B-cell lymphoma: Phase I experience from the ALPHA2/ALPHA clinical studies
    Journal Article

    Locke, F. L.; Munoz, J. L.; Tees, M. T.; Lekakis, L. J.; de Vos, S.; Nath, R.; Stevens, D. A.; Malik, S. A.; Shouse, G. P.; Hamadani, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Misdiagnosis in breast imaging: A statement paper from European Society Breast Imaging (EUSOBI)—Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis
    Review

    Thomassin-Naggara, I.; Athanasiou, A.; Kilburn-Toppin, F.; Forrai, G.; Ispas, M.; Lesaru, M.; Giannotti, E.; Pinker-Domenig, K.; Van Ongeval, C.; Mann, R. M.; more...
    European Radiology (2025)

    Fulltext@MSK | Save
  • Patient-reported outcomes from DESTINY-Breast04: Trastuzumab deruxtecan versus physician’s choice of chemotherapy in patients with HER2-low mBC
    Journal Article

    Ueno, N. T.; Cottone, F.; Dunton, K.; Jacot, W.; Yamashita, T.; Sohn, J.; Tokunaga, E.; Prat, A.; Tsurutani, J.; Park, Y. H.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: An International Thyroid Oncology Group statement
    Review

    Leboulleux, S.; Boucai, L.; Busaidy, N.; Durante, C.; Fagin, J. A.; Fazeli, S.; Gianoukakis, A. G.; Haugen, B. R.; Kang, H.; Konda, B.; more...
    Lancet Diabetes & Endocrinology (2025)

    Fulltext@MSK | Save
  • A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
    Journal Article

    Gouda, M. A.; Voss, M. H.; Tawbi, H.; Gordon, M.; Tykodi, S. S.; Lam, E. T.; Vaishampayan, U.; Tannir, N. M.; Chaves, J.; Nikolinakos, P.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Expert consensus on treating HR+/HER2-metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists
    Journal Article

    Rugo, H. S.; Bardia, A.; Gradishar, W. J.; Hamilton, E. P.; Hurvitz, S. A.; Jhaveri, K.; Mahtani, R.; Tolaney, S. M.
    Breast (2025)

    Fulltext@MSK | Save
  • Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: A prospective pilot study
    Research Letter

    Pegoraro, F.; Catamerò, F.; Allegretta, F.; Palazzini, G.; Peyronel, F.; Diamond, E. L.; Vaglio, A.
    Blood Advances (2025)

    Fulltext@MSK | Save